Celgene in talks to buy Juno Therapeutics on heels of Impact deal
January 16, 2018 at 21:45 PM EST
More M&A deals like these are expected due to the tax code enticing U.S.-based companies.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|